Published Articles

Practical perspectives from bioprocess principals.

Our published work covers the operational and contractual realities of bioprocess consulting in the biopharmaceutical sector. Each article is grounded in direct project experience.

01 INDUSTRY REFLECTION

Resource Management for Project Leaders

A short reflection on what project and program managers face when internal resources cannot match timeline pressure, and when bringing in qualified outside contractors becomes the right move.

Read on LinkedIn
02 INDUSTRY REFLECTION

Supporting Therapeutic Innovators

A brief note on the firm's mission to support those designing the next generation of therapeutic drugs and cell therapies, with manufacturing design, characterization, scale up, optimization, and validation expertise.

Read on LinkedIn
03 INDUSTRY REFLECTION

Forty Five Years in Bioprocess

A perspective piece on the institutional knowledge EBS principals bring after decades of watching the field evolve, from early recombinant DNA work through monoclonal antibodies, antibody drug conjugates, and the shift from stainless steel to single use systems.

Read on LinkedIn
04 INDUSTRY PERSPECTIVE

When to Engage Consulting and Contract Services

A case for bringing qualified bioprocess consultants in early during product development. The argument focuses on how early technical depth compresses timelines, strengthens regulatory position, and avoids the rework costs that follow underqualified early decisions.

Read full article
05 INDUSTRY SERIES · PART 1

Contracting in the Biopharmaceutical Sector

The opening installment examines why biopharma companies engage contract resources, the historical reliance on full time staff, and the rise of CROs, CDMOs, and boutique providers across the modern landscape.

Read full article
06 INDUSTRY SERIES · PART 2

Contracting in the Biopharmaceutical Sector

The second installment defines CROs and CDMOs grounded in FDA guidance, walks through where each fits in the drug development arc, and introduces EBS as a boutique alternative to traditional staffing agencies.

Read full article
07 INDUSTRY SERIES · PART 3

Contracting in the Biopharmaceutical Sector

The final installment looks at how the contract services market is shifting, including the move from W2 staffing models toward 1099 independent contractors and what that means for skill levels, retention, and engagement quality.

Read full article
DISCUSSION

Have a topic worth discussing?

If a piece here raised a question or you have a bioprocess challenge worth a conversation, send us a note. A principal responds to every inquiry within one business day.

Start a conversation

Want to discuss a specific challenge?

Our principals respond to every inquiry within one business day.

Get in touch